Skip to main content
SpringerLink
Log in

Adjuvant chemotherapy of soft tissue sarcomas

  • Chapter
Multidisciplinary Treatment of Soft Tissue Sarcomas

Part of the book series: Cancer Treatment and Research ((CTAR,volume 67))

Abstract

Adequate surgical resection, with or without radiotherapy, remains the primary potentially curative treatment of soft tissue sarcomas, as most patients present without clinically evident metastases. Unfortunately, metastases subsequently occur in up to half of these cases [1–4], despite adequate local control, and it is only with the elimination of hematogenously borne micrometastases that further improvements in survival will occur.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Enneking WF, Spanier SS, Malawer MM: The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer 47:1005–1023, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Russell WO, Kohen J, Enzinger F, Hajdu SI, Heise H, Martin RG, Meissner W, Miller WT, Schmitz RL, Suit HD: A clinical and pathological staging system for soft tissue sarcomas. Cancer 40:1562–1570, 1977.

    Article  PubMed  CAS  Google Scholar 

  3. Romsdahl MM, Lindberg RD, Martin RG: Patterns of failure after treatment of soft tissue sarcoma. Cancer Treat Symp 2:251–258, 1983.

    Google Scholar 

  4. Suit HD: Patterns of failure after treatment of sarcoma of soft tissue by radical surgery or by conservative surgery and radiation. Cancer Treat Symp 2:241–246, 1983.

    Google Scholar 

  5. Schable FM: Rationale for adjuvant chemotherapy. Cancer 39:2875–2882, 1977.

    Article  Google Scholar 

  6. Eilber FR, Giuliano AE, Huth JF, Morton DL: A randomized prospective trial using postoperative chemotherapy (adriamycin) in high grade extremity soft-tissue sarcoma. Am J Clin Oncol (CCT) 11:39–45, 1988.

    Article  CAS  Google Scholar 

  7. Wilson RE, Wood WC, Lerner HL, Antman K, Amato D, Corson JM, Proppe K, Harmon D, Carey R, Greenberger J, Suit H: Doxorubicin chemotherapy in the treatment of soft tissue sarcoma: Combined results of two randomized trials. Arch Surg 121:1354–1359, 1986.

    Article  PubMed  CAS  Google Scholar 

  8. Antman K, Ryan L, Borden E, Wood WC, Lerner HL, Corson JM, Carey R, Suit H, Balcerak S, Elias A, Baker L: Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of literature. In: Salmon SE, ed. Adjuvant Therapy of Cancer VI. Philadelphia: WB Saunders, 1990, pp 529–543.

    Google Scholar 

  9. Baker LH: Adjuvant therapy for soft tissue sarcomas. In: Ryan JR, Baker LO, eds. Recent Concepts in Sarcoma Treatment. Dordecht: Kluwer Academic Publishers, 1988, pp 131–136.

    Google Scholar 

  10. Alvegard TA, Sigurdsson H, Mouridsen H, Solheim O, Unsgaard B, Ringborg U, Dahl O, Nordentoft AM, Blomqvist C, Rydholm A, Stener B, Ranstam J: Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcoma: A randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 7:1504–1513, 1989.

    PubMed  CAS  Google Scholar 

  11. Gherlinzoni F, Bacci G, Picci P, Capanna R, Calderoni P, Lorenzi EG, Bernini M, Emiliani E, Barbieri E, Normand A, Campanacci M: A randomized trial for the treatment of high grade soft tissue sarcomas of the extremities: Preliminary observations. J Clin Oncol 4:552–558, 1986.

    PubMed  CAS  Google Scholar 

  12. Picci P, Bacci G, Gherlinzoni F, Capanna R, Mercuri M, Ruggieri P, Baldini N, Avella M, Pignatti G, Manfrini M: Results of a randomized trial for a treatment for the treatment of localized soft tissue tumors (STS) of the extremities in adult patients. In: Ryan JR, Baker LO, eds. Recent Concepts in Sarcoma Treatment. Dordecht: Kluwer Academic Publishers, 1988, pp 144–148.

    Chapter  Google Scholar 

  13. Gherlinzoni F, Pignatti G, Fontana M, Giunti A: Soft tissue sarcomas: The experience at the Istituto Ortopedico Rizzoli. Chir Organi Mov 75:150–154, 1990.

    PubMed  CAS  Google Scholar 

  14. Sylvester R: Soft-tissue sarcomas of the extremities (letter). J Clin Oncol 5:321–322, 1987.

    PubMed  CAS  Google Scholar 

  15. Lindberg RD, Murphy WK, Benjamin RS, Sinkovics JG, Martin RG, Romsdhal MM, Jesse RH, Russell HO: Adjuvant chemotherapy in the treatment of primary soft tissue sarcomas: A preliminary report. In: Management of Primary Bone and Soft Tissue Tumors. Chicago: Year Book Medical, 1986, pp 343–352.

    Google Scholar 

  16. Benjamin RS, Terjanian TO, Genoglio CJ, Barkley HT, Evans HC, Murphy WK, Martin RG: The importance of combination chemotherapy for adjuvant treatment of high risk patients with soft tissue sarcomas of the extremities. In: Salmon SE, ed. Adjuvant Therapy of Cancer V. New York: Grune & Stratton, 1987, pp 735–744.

    Google Scholar 

  17. Edmonson JH, Fleming TR, Ivans JC, Burgert O, Soule EH, O’Connell MJ, Sim FH, Ahmann DL: A randomized study of systemic chemotherapy following complete excision of non-osseous sarcomas. J Clin Oncol 2:1390–1396, 1984.

    PubMed  CAS  Google Scholar 

  18. Rosenberg SA: Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas. Cancer Treat Rep 68:1067–1078, 1984.

    PubMed  CAS  Google Scholar 

  19. Rosenberg SA: Adjuvant chemotherapy of adult patients with soft tissue sarcoma. In: De Vita V, Hellman S, Rosenberg S, eds. Important Advances in Oncology. Philadelphia: JB Lippincott, 1985, pp 273–294.

    Google Scholar 

  20. Baker AR, Chang AE, Glatstein E, Rosenberg SA: National Cancer Institute experience in the management of high grade extremity soft tissue sarcoma. In: Ryan JR, Baker LO, eds. Recent Concepts in Sarcoma Treatment. Dordrecht: Kluwer Academic Publishers, 1988, pp 123–130.

    Chapter  Google Scholar 

  21. Chang AE, Kinsella T, Glatstein E, Baker AR, Sindelar WF, Lotze MT, Danforth DN, Sugarbaker PH, Lack EE, Steinberg SM, White DE, Rosenberg SA: Adjuvant chemotherapy for patients with high grade soft tissue sarcomas of the extremity. J Clin Oncol 6:1491–1500, 1988.

    PubMed  CAS  Google Scholar 

  22. Glenn J, Kinsella T, Glatstein E, Tepper J, Baker A, Sugarbaker P, Sindelar W, Roth J, Brennan M, Costa J, Seipp C, Wesley R, Young RC, Rosenberg SA: A randomized, perspective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast and trunk. Cancer 55:1206–1214, 1985.

    Article  PubMed  CAS  Google Scholar 

  23. Bramwell V, Rouesse J, Steward W, Santoro A, Buesa J, Thomas D, Sylvester R: Reduced rate of local recurrence following CYVADIC chemotherapy in localized soft tissue sarcoma. Proc Am Soc Clin Oncol 8:320, 1989.

    Google Scholar 

  24. Bramwell V, Rouesse J, Steward W, Santoro A, Buesa J, Thomas D, Van Glabbeke M: Five year results of CYVADIC adjuvant chemotherapy for soft tissue sarcoma: An EORTC randomized trial (abstract). Eur J Cancer 27(Suppl 2):S161, 1991.

    Google Scholar 

  25. Bui NB, Maree D, Coindre JM, Bonchon F, Kantor G, Avril A, Ravaud A: First results of a perspective randomized study of CYVADIC adjuvant chemotherapy in adults with operable high risk soft tissue sarcoma. Proc Am Soc Clin Oncol 8:318, 1989.

    Google Scholar 

  26. Ravaud A, Bui NB, Coindre JM, Kantor G, Stockle E, Lagarde P, Becouarn Y, Chauvergne J, Bonichon F, Maree D: Adjuvant chemotherapy with Cyvadic in high risk soft tissue sarcoma: A randomized prospective trial. In: Salmon SE, ed. Adjuvant Therapy of Cancer VI. Philadelphia: WB Saunders, 1990, pp 556–566.

    Google Scholar 

  27. Antman K, Ryan L, Borden E, Wood W, Lerner H, Corson J, Carey R, Suit H, Balcerak S, Sherman M, Baker L: Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results. Proc Am Soc Clin Oncol 9:311, 1990.

    Google Scholar 

  28. L’abbe KA, Detsky AS, O’Rourke K: Meta-analysis in clinical research. Ann Intern Med 107:224–233, 1987.

    CAS  Google Scholar 

  29. Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, Beecham J, Park R, Silverberg S: A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study. J Clin Oncol 3:1240–1245, 1985.

    PubMed  CAS  Google Scholar 

  30. Jones GW, Chouinard E, Patel M: Adjuvant Adriamycin (doxorubicin) in adult patients with soft-tissue sarcomas: A systematic overview and quantitative meta-analysis (abstract). Clin Invest Med 14(Suppl 19):A772, 1991.

    Google Scholar 

  31. Dresdale A, Bonow RO, Wesley R, Palmeri ST, Barr L, Mathison D, D’Angelo T, Rosenberg SA: Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from post-surgical adjuvant treatment of patients with soft tissue sarcomas. Cancer 52:51–60, 1983.

    Article  PubMed  CAS  Google Scholar 

  32. Ettinghausen SE, Bonow RO, Palmeri ST, Seipp CA, Steinberg SM, White DE, Rosenberg SA: Prospective study of cardiomyopathy induced by adjuvant doxorubicin therapy in patients with soft tissue sarcomas. Arch Surg 121:1445–1491, 1986.

    Article  PubMed  CAS  Google Scholar 

  33. Harris J, Das Gupta T, Vogelzang N, Badrinath K, Bonomi P, Deser R, Locker G, Blough R, Johnson C: Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): An American Cancer Society/Illinois Cancer Council Study. Cancer Treat Rep 70:293–294, 1986.

    PubMed  CAS  Google Scholar 

  34. Fidler IJ: Optimization and limitations of systemic treatment of murine melanoma metastases with liposomes containing muramyl tripeptide phosphatidylethanolamine. Cancer Immunol Immunother 21:169–173, 1986.

    Article  PubMed  CAS  Google Scholar 

  35. Fidler IJ, Jessup JM, Fogler WE, Staerkel R, Mazumder A: Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma. Cancer Res 46:994–998, 1986.

    PubMed  CAS  Google Scholar 

  36. Jarowenkod G, Sigler SC, Pellis NR: Muramyl tripeptide: An effective immunotherapy in the surgical setting for pediatric abdominal neoplasms. J Pediatr Surg 22:497–500, 1987.

    Article  Google Scholar 

  37. MacEwen EG, Kurzman ID, Rosenthal RC, Smith BW, Manley PA, Roush JK, Howard PE: Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. J Natl Cancer Inst 31:925–928, 1989.

    Google Scholar 

  38. Murray JL, Kleinerman ES, Cunningham JE, Tatom JR, Andrejcio K, Lepe-Zuniga J, Lamki LM, Rosenblum MG, Frost H, Gutterman JU, Fidler IJ, Krakoff IH: Phase I trial of liposome muramyl tripeptide phosphatidylethanolamine in cancer patients. J Clin Oncol 7:1915–1925, 1989.

    PubMed  CAS  Google Scholar 

  39. Urba WJ, Hartmann LC, Longo DL, Steis RG, Smith JW, Kedar I, Creekmore S, Sznol M, Conlon K, Kopp WC, Huber C, Herold M, Alvord WG, Snow S, Clark JW: Phase I and immunomodulatory study of muramyl peptide, muramyl tripeptide phosphatidylethanolamine. Cancer Res 50:2979–2986, 1990.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Wilson C. Mertens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivien H.C. Bramwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, Rotterdam Cancer Institute, Rotterdam, The Netherlands

    Jaap Verweij

  2. Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands

    Herbert M. Pinedo

  3. Department of Radiation Medicine Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Herman D. Suit

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mertens, W.C., Bramwell, V.H. (1993). Adjuvant chemotherapy of soft tissue sarcomas. In: Verweij, J., Pinedo, H.M., Suit, H.D. (eds) Multidisciplinary Treatment of Soft Tissue Sarcomas. Cancer Treatment and Research, vol 67. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3082-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3082-4_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6346-0

  • Online ISBN: 978-1-4615-3082-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation